March 25th, 2012
Is it Impossible to Break into Clinical Research? Debunking a Common Misperception
Jeremiah Depta, MD
Using the National Cardiovascular Data Registry to identify and pursue good research opportunities
March 25th, 2012
The Pie-ing Game: How Do We Carve up Shrinking Reimbursements?
Sandeep Mangalmurti, MD, JD
The ABCs of RVUs, and how they affect your practice
March 25th, 2012
Eric Peterson to Succeed Bob Harrington as Director of the Duke Clinical Research Institute
Larry Husten, PHD
The Duke Clinical Research Institute has announced that its new director will be Eric Peterson. The DCRI was founded by Robert Califf, who, as the director of the Duke Translational Medicine Institute (DTMI), will be Peterson’s boss. The DCRI’s second director, Robert Harrington, announced earlier this year that he was leaving Duke to become the chairman of the department of medicine […]
March 24th, 2012
Whither Conferences? Searching for the South by Southwest Passage
John Ryan, MD
While our conferences shrink, events that put the attendee at the center are growing. What the ACC and AHA learn from the likes of South by Southwest?
March 24th, 2012
Opening with a Bang
Megan Coylewright, MD MPH
Megan Coylewright blogs on the opening session, from Star Wars excess to stem cell disappointment
March 24th, 2012
On the Shoulders of Giants
Tariq Ahmad, MD, MPH
Blogging from ACC.12, Tariq Ahmad pauses to consider the history of innovation in cardiology.
March 24th, 2012
Honoring the Legends
Megan Coylewright, MD MPH
Megan Coylewright reflects on lessons from the five legends honored in ACC’s new lecture series.
March 24th, 2012
Novel Antiplatelet Agent Reduces CV Events But Increases Bleeding
Larry Husten, PHD
Vorapaxar, the novel antiplatelet agent from Merck, appears to effectively reduce cardiovascular death and ischemic events in patients with MI, ischemic stroke, or peripheral vascular disease, but its potential utility is clouded by bleeding complications, including intracranial hemorrhage. Results from the TRA 2P-TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial were presented […]
March 23rd, 2012
Early Morning, Early Start to ACC
Megan Coylewright, MD MPH
One of five Cardiology Fellows blogging at ACC.12 hits the ground running, early on Friday.
March 22nd, 2012
ACC 2012 at Chicago: Hosting the World
John Ryan, MD
Chicago is a wonderful city for meetings, and the ACC should be a great learning experience. Here’s how to get the most out of the experience.
NEJM Journal Watch — Recent Cardiology Articles- Sudden Cardiac Death in the U.S.: 20-Year Trends
- Oral Semaglutide Approved to Lower Cardiovascular Risk in High-Risk Patients with Type 2 Diabetes
- Covid-19 Vaccines Improve Heart Outcomes
- Detecting Atrial Fibrillation After Transient In-Hospital Episodes
- Cardiac Involvement with Mycoplasma pneumonia: More Common Than Previously Thought